SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (7255)9/19/1998 12:43:00 AM
From: Tharos  Read Replies (1) | Respond to of 17367
 
George, enjoyed the link. I found it very interesting that Neuprex's uses included "Gram negative sepsis."



To: aknahow who wrote (7255)9/19/1998 4:49:00 PM
From: LarryS  Respond to of 17367
 
Reviewed your site, pretty good for
newbies(and I am one).

Can't wait for DSMB recommendation...
regardless of their decision I will be very interested in the wording of their report.

I expected a big jump in X if the trial
was ended, but with the market the way
it is that might not happen. If X has
the product they think they do it will
be a slow move up as others understand
the power of X's products. Maybe $40 in
a couple years instead of this week. :-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News